SpyGlass Pharma, Inc. Common Stock
SGPAnalyst Consensus
Price Target Trend
Rating Trend
Recent Price Targets
| Date | Firm | Analyst | Target | Price Then | Source |
|---|---|---|---|---|---|
| Oct 5, 2026 | H.C. Wainwright | Yi Chen | $37.00(+48%) | $24.92 | StreetInsider |
| Aug 14, 2026 | Raymond James | Christopher Raymond | $39.00(+55%) | $25.17 | TheFly |
| Mar 3, 2026 | Jefferies | Dennis Ding | $62.00(+132%) | $26.73 | StreetInsider |
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| HC Wainwright & Co. | maintain | Buy | Oct 21, 2026 |
| HC Wainwright & Co. | maintain | Buy | Oct 5, 2026 |
Earnings History
| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 6, 2026 | $-0.59 | $-0.51 | — | — |
| May 15, 2026 | $-0.69 | $-0.67 | — | — |
| Mar 26, 2026 | $-5.72 | $-0.57 | — | — |
| Dec 3, 2025 | $-0.45 | — | — | — |
News
IRVINE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Stifel 2026 Healthcare Conference Date: Thursday, November 12, 2026Time: 8:00 a.m.
Groundbreaking 4-year safety and efficacy results: 37% reduction in mean intraocular pressure (IOP) across all dose groups 86% of patients remained off all topical IOP-lowering drops 90% of patients maintained ≥20/25 best corrected distance visual acuity (BCDVA) No product-related adverse events were reported IRVINE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company dedicated to transforming the …
SYDNEY--(BUSINESS WIRE)--EdgeConneX®, a pioneer in global Build-to-Suit and Build-to-Density digital infrastructure solutions, today announced its entry into the Australian market through a 50-50 joint venture partnership with Stockland (ASX: SGP). The companies plan to develop, own, and operate a portfolio of hyperscale data center campuses across Australia, starting with Sydney and Melbourne. The EdgeConneX Stockland Data Center partnership combines Stockland's land, development, and project.
IRVINE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”) announced today the acquisition of all the outstanding shares of common stock of Advanced Vision Science, Inc. (AVS), an ophthalmic medical device company and manufacturer of intraocular lenses (IOLs) and lens materials, for approximately $13 million in cash. This acquisition secures scalable commercial IOL manufacturing capacity for SpyGlass Pharma. AVS was a wholly owned subsi…
SpyGlass Pharma, Inc. (SGP) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
IRVINE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Wells Fargo 21 st Annual Healthcare Conference Date: Wednesday, September 9, 2026 Format: 1x1 Meetings only Citi's 2026 Biopharma Back to School Conference Date: Thursday, September 10, 2026Time: 10:40 a.m.
Wall Street flipped the script Friday with a wave of surprise upgrades and downgrades hitting names like Wayfair, Roku, and Fox Corporation, while cooler inflation data reshuffled bets across stocks, bonds, oil, and crypto all at once.